SCHEMBL20101473

SCHEMBL20101473

Cc1ccc2ncc(CC(=O)ON3C(=O)CCC3=O)c(-c3ccccc3)c2c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.44
POLB P06746 1/20 0.44
PSMB8 P28062 1/20 0.40
PSMB5 P28074 1/20 0.40
THRB P10828 1/20 0.40
HTT P42858 3/20 0.39
NPSR1 Q6W5P4 3/20 0.39
HPGD P15428 2/20 0.39
MAPT P10636 3/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
MAPK8 P45983 1/20 0.38
KDM4E B2RXH2 6/20 0.38
KLK7 P49862 1/20 0.38
MAPK1 P28482 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
PIM1 P11309 1/20 0.38
MEN1 O00255 3/20 0.37
KMT2A Q03164 3/20 0.37
ATM Q13315 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16624723 0.87 ALDH1A1 (0.41) ALDH1A1PSMB8PSMB5HTTNPSR1
SCHEMBL27971255 0.81 KDM4E (0.48) ALDH1A1POLBHTTNPSR1HPGD
SCHEMBL17954338 0.73 ALDH1A1 (0.49) ALDH1A1HTTNPSR1HPGDMAPT
SCHEMBL16624680 0.72 ALDH1A1 (0.53) ALDH1A1POLBTHRBHTTNPSR1
SCHEMBL16624812 0.71 SMN1; SMN2 (0.64) ALDH1A1PSMB8PSMB5HTTNPSR1
SCHEMBL27971113 0.70 ALDH1A1 (0.60) ALDH1A1POLBHTTNPSR1HPGD
SCHEMBL16624654 0.70 TDP1 (0.39) PSMB8PSMB5HPGDSMN1; SMN2MAPK1
SCHEMBL16624688 0.69 ALDH1A1 (0.50) ALDH1A1HTTNPSR1HPGDMAPT
SCHEMBL19658180 0.69 KMT2A (0.41) ALDH1A1PSMB8PSMB5HPGDMAPT
SCHEMBL21610292 0.69 ALDH1A1 (0.49) ALDH1A1HTTNPSR1HPGDMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3052107-B1 ORGANIC COMPOUNDS TO TREAT HEPATITIS B VIRUS NOVARTIS AG (CH) 2018-05-02 EP disclosed